COVID-19

FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease

Simple Blood Test Aids Risk Assessment for Approximately 14 Million Eligible Patients in the United States Diabetic Kidney Disease is the…

12 months ago

Bionano Announces the Stratys™ System for OGM and VIA™ Software for Hematologic Malignancies

The Stratys™ instrument for optical genome mapping (OGM) will enable a four-fold increase in raw data generation rate compared to…

12 months ago

Advanced Health Intelligence Ltd Announces Implementation of ADS Ratio Change

NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) -- Advanced Health Intelligence Ltd (ASX/NASDAQ:AHI) (“Advanced Health Intelligence”, “AHI” or the “Company”)…

12 months ago

Zenocutuzumab (Zeno) granted Breakthrough Therapy Designation by the U.S. Food & Drug Administration for the treatment of NRG1+ pancreatic cancer

UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 29, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company…

12 months ago

Vir Biotechnology Appoints Sasha Damouni Ellis as Executive Vice President and Chief Corporate Affairs Officer

SAN FRANCISCO, June 29, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Sasha Damouni…

12 months ago

Aquestive Therapeutics Provides Business Update and Announces Chief Medical Officer Appointment

Submitted NDA for Libervant™ (diazepam) Buccal Film for treatment of seizure clusters in patients between two and five years of…

12 months ago

BioSig Joins Webull Corporate Connect

Webull’s investor community can now access real-time BioSig investor communications and Q&AWestport, CT, June 29, 2023 (GLOBE NEWSWIRE) -- BioSig…

12 months ago

NeuBase Presents Non-Human Primate Data Illustrating Stealth Editors™ are Non-Immunogenic, Opening the Door to Redosing

New preclinical data validates that Stealth Editors™ are non-immunogenic, as featured in a poster presentation at the 28th American Peptide…

12 months ago

Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US

The study was conducted over two days by a team of global key opinion leaders and with participation of executives…

12 months ago

Urica Therapeutics Announces Topline Data from the Phase 1 Clinical Trial Evaluating Dotinurad in Healthy Volunteers in the United States

Data from Phase 1 clinical trial in healthy volunteers show comparable pharmacokinetic, pharmacodynamic and safety profile between U.S. and Japanese…

12 months ago